Synthetic Biology Workshop 2017 - Panel Discussion
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Johnson Matthey, a leading sustainable technologies company, seeks startups in artificial intelligence and automation for collaboration.